The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Koreshkina M.I.

Headache Treatment Center Scandinavia

What to do

Authors:

Koreshkina M.I.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(8): 18‑24

Read: 141 times

Buy for 300₽
Contact the author
Table of contents

To cite this article:

Koreshkina MI. What to do. Non Nocere. New Therapeutic Journal. 2025;(8):18‑24. (In Russ.)

 
 
 
ЭндоКард
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

Diagnosis and treatment of primary headaches in outpatient settings. New Russian and international recommendations.

Authors:

Koreshkina M.I.

Headache Treatment Center Scandinavia

Close metadata

References:

  1. Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022 Apr 12;23(1):34.  https://doi.org/10.1186/s10194-022-01402-2
  2. Seddik AH, Branner JC, Ostwald DA, Schramm SH, Bierbaum M, Katsarava Z. The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in Germany. Cephalalgia. 2020 Dec;40(14):1551-1560. https://doi.org/10.1177/0333102420944842
  3. Waliszewska-Prosół M, Montisano DA, Antolak M, et al. The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study. J Headache Pain. 2024 Mar 4;25(1):27.  https://doi.org/10.1186/s10194-024-01735-0
  4. Buse DC, Pozo-Rosich P, Dupont-Benjamin L, et al. Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment. J Headache Pain. 2023 Aug 24;24(1):115.  https://doi.org/10.1186/s10194-023-01655-5
  5. Dodick DW, Reed ML, Lee L, et al. Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States. Headache. 2024 Apr;64(4):361-373.  https://doi.org/10.1111/head.14684
  6. GBD2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2133-2161. https://doi.org/10.1016/S0140-6736(24)00757-8
  7. Raggi A, Leonardi M. Burden of brain disorders in Europe in 2017 and comparison with other non-communicable disease groups. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):104-105.  https://doi.org/10.1136/jnnp2019-320466
  8. Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain. 2019 May 21;20(1):57.  https://doi.org/10.1186/s10194-018-0899-2
  9. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9
  10. Olesen J, Jensen RH. The Global Campaign Against Headache and its future relation to IHS and WHO. Cephalalgia. 2023 Apr;43(4):3331024231159625. https://doi.org/10.1177/03331024231159625
  11. Ayzenberg I, Katsarava Z, Sborowski A, et al. Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol. 2014 May;21(5):758-765.  https://doi.org/10.1111/ene.12380
  12. Buse DC, Pozo-Rosich P, Dupont-Benjamin L, et al. Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment. J Headache Pain. 2023 Aug 24;24(1):115.  https://doi.org/10.1186/s10194-023-01655-5
  13. World Health Organization. Atlas of headache disorders and resources in the world 2011. https://iris.who.int/bitstream/handle/10665/44571/9789241564212_eng.pdf
  14. Mehuys E, Paemeleire K, Van Hees T, et al. Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol. 2012 Aug;19(8):1093-1099. https://doi.org/10.1111/j.1468-1331.2012.03681.x
  15. Steiner TJ, Jensen R, Katsarava Z, et al. Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description. J Headache Pain. 2021 Jul 21;22(1):78.  https://doi.org/10.1186/s10194-021-01265-z
  16. Information portal about headache diagnosis and treatment methods, “All About Headaches.” https://headinfo.ru/
  17. Ministry of Health of the Russian Federation. Clinical guidelines. Migraine. Year of approval: 2024. ID: 295_4. Age category: adults. https://cr.minzdrav.gov.ru/view-cr/295_4
  18. Ministry of Health of the Russian Federation. Clinical guidelines. Tension headache. Year of approval: 2024. ID: 162_3. Age category: adults. https://cr.minzdrav.gov.ru/view-cr/162_3
  19. Order of the Ministry of Health of the Russian Federation dated May 23, 2023, No. 257n “On the Approval of the Standard of Medical Care for Adults with Migraine (Diagnosis and Treatment).” Registered on June 27, 2023, No. 74006. https://publication.pravo.gov.ru/document/0001202306270022
  20. Order of the Ministry of Health of the Russian Federation dated May 12, 2023, No. 225n “On the Approval of the Standard for Primary Health Care for Adults with Tension Headaches (Diagnosis and Treatment).” Registered on June 21, 2023, No. 73931. https://publication.pravo.gov.ru/document/0001202306210042
  21. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013 Jul;33(9):629-808.  https://doi.org/10.1177/0333102413485658
  22. GBD2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024 Apr;23(4):344-381.  https://doi.org/10.1016/S1474-4422(24)00038-3
  23. Cousins G, Hijazze S, Van de Laar FA, Fahey T. Diagnostic accuracy of the ID Migraine: a systematic review and meta-analysis. Headache. 2011 Jul-Aug;51(7):1140-1148. https://doi.org/10.1111/j.1526-4610.2011.01916.x
  24. Kong X, Chen J, Jiang H, et al. Testing of diagnosis criteria of tension – type headache: A multicenter clinical study. Cephalalgia. 2018 Oct;38(12):1833-1840. https://doi.org/10.1177/0333102418759784
  25. Onan D, Younis S, Wellsgatnik WD, et al. Debate: differences and similarities between tension-type headache and migraine. J Headache Pain. 2023 Jul 21;24(1):92.  https://doi.org/10.1186/s10194-023-01614-0
  26. Puledda F, Sacco S, Diener HC, et al. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia. 2024 Aug;44(8):3331024241252666. https://doi.org/10.1177/03331024241252666
  27. Ashina M, Buse DC, Ashina H, et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021 Apr 17;397(10283):1505-1518. https://doi.org/10.1016/S0140-6736(20)32342-4
  28. Package insert – information for patients. Nurofen® Express Forte, 400 mg, capsules. LP No. (006327)-(RG-RU) dated March 20, 2025. https://grls.minzdrav.gov.ru/Grls_View_v2.aspx?routingGuid=958cee8a2bc5-48a2-981c-bee45c285425
  29. Moore AR, Derry S, Straube S, Ireson-Paine J, Wiffen PJ. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014 Jan;155(1):14-21.  https://doi.org/10.1016/j.pain.2013.08.013
  30. Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021 Aug;17(8):501-514.  https://doi.org/10.1038/s41582-021-00509-5
  31. Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review. Adv Ther. 2020 Jan;37(1):61-82.  https://doi.org/10.1007/s12325-019-01144-9
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.